Justin Mitchell Krause

Array ( [id] => 2515678 [patent_doc_number] => 04874705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-10-17 [patent_title] => 'DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella' [patent_app_type] => 1 [patent_app_number] => 6/805824 [patent_app_country] => US [patent_app_date] => 1985-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 12 [patent_no_of_words] => 16071 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/874/04874705.pdf [firstpage_image] =>[orig_patent_app_number] => 805824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2664066 [patent_doc_number] => 04935233 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-06-19 [patent_title] => 'Covalently linked polypeptide cell modulators' [patent_app_type] => 1 [patent_app_number] => 6/803748 [patent_app_country] => US [patent_app_date] => 1985-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 9114 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/935/04935233.pdf [firstpage_image] =>[orig_patent_app_number] => 803748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2416028 [patent_doc_number] => 04746651 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-05-24 [patent_title] => 'Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives' [patent_app_type] => 1 [patent_app_number] => 6/798629 [patent_app_country] => US [patent_app_date] => 1985-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11497 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/746/04746651.pdf [firstpage_image] =>[orig_patent_app_number] => 798629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2302275 [patent_doc_number] => 04673669 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-06-16 [patent_title] => 'Pharmaceutical composition containing a derivative of para-aminobenzoic acid as an active ingredient' [patent_app_type] => 1 [patent_app_number] => 6/786851 [patent_app_country] => US [patent_app_date] => 1985-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 6516 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/673/04673669.pdf [firstpage_image] =>[orig_patent_app_number] => 786851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2659193 [patent_doc_number] => 04946674 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-08-07 [patent_title] => 'Process for treatment of rheumatic diseases' [patent_app_type] => 1 [patent_app_number] => 6/782221 [patent_app_country] => US [patent_app_date] => 1985-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5604 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/946/04946674.pdf [firstpage_image] =>[orig_patent_app_number] => 782221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2555968 [patent_doc_number] => 04816440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-03-28 [patent_title] => 'Stable formulation of biologically active proteins for parenteral injection' [patent_app_type] => 1 [patent_app_number] => 6/780551 [patent_app_country] => US [patent_app_date] => 1985-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10795 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/816/04816440.pdf [firstpage_image] =>[orig_patent_app_number] => 780551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2524202 [patent_doc_number] => 04888170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-12-19 [patent_title] => 'Vaccines obtained from antigenic gene products of recombinant genes' [patent_app_type] => 1 [patent_app_number] => 6/773894 [patent_app_country] => US [patent_app_date] => 1985-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10973 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/888/04888170.pdf [firstpage_image] =>[orig_patent_app_number] => 773894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2422656 [patent_doc_number] => 04780413 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-10-25 [patent_title] => 'Production of antiviral agents' [patent_app_type] => 1 [patent_app_number] => 6/769670 [patent_app_country] => US [patent_app_date] => 1985-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3873 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/780/04780413.pdf [firstpage_image] =>[orig_patent_app_number] => 769670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2424872 [patent_doc_number] => 04780530 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-10-25 [patent_title] => 'Novel interferon alphas' [patent_app_type] => 1 [patent_app_number] => 6/763791 [patent_app_country] => US [patent_app_date] => 1985-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 8082 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/780/04780530.pdf [firstpage_image] =>[orig_patent_app_number] => 763791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2241436 [patent_doc_number] => 04622223 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-11-11 [patent_title] => 'Broad spectrum vaccine against gonorrhea' [patent_app_type] => 1 [patent_app_number] => 6/759123 [patent_app_country] => US [patent_app_date] => 1985-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5089 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/622/04622223.pdf [firstpage_image] =>[orig_patent_app_number] => 759123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2410928 [patent_doc_number] => 04743445 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-05-10 [patent_title] => 'Method for treatment of essential (hemorrhagic) thrombocythemia' [patent_app_type] => 1 [patent_app_number] => 6/758729 [patent_app_country] => US [patent_app_date] => 1985-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2621 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/743/04743445.pdf [firstpage_image] =>[orig_patent_app_number] => 758729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2345062 [patent_doc_number] => 04656144 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-04-07 [patent_title] => 'Immunoparticles and process for preparing same' [patent_app_type] => 1 [patent_app_number] => 6/757761 [patent_app_country] => US [patent_app_date] => 1985-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4538 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/656/04656144.pdf [firstpage_image] =>[orig_patent_app_number] => 757761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2447747 [patent_doc_number] => 04758428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-07-19 [patent_title] => 'Multiclass hybrid interferons' [patent_app_type] => 1 [patent_app_number] => 6/755265 [patent_app_country] => US [patent_app_date] => 1985-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 9015 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/758/04758428.pdf [firstpage_image] =>[orig_patent_app_number] => 755265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2384504 [patent_doc_number] => 04737462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-04-12 [patent_title] => 'Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-.beta.' [patent_app_type] => 1 [patent_app_number] => 6/753717 [patent_app_country] => US [patent_app_date] => 1985-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 7041 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/737/04737462.pdf [firstpage_image] =>[orig_patent_app_number] => 753717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2637367 [patent_doc_number] => 04898931 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-02-06 [patent_title] => 'Novel human interferon-.gamma. polypeptide derivative' [patent_app_type] => 1 [patent_app_number] => 6/751205 [patent_app_country] => US [patent_app_date] => 1985-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8877 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/898/04898931.pdf [firstpage_image] =>[orig_patent_app_number] => 751205 [rel_patent_id] =>[rel_patent_doc_number] =>)